Track topics on Twitter Track topics that are important to you
Dallas—OncoNano Medicine, which is developing an imaging agent to help surgeons better remove tumors, has raised $11.7 million in Series A funding. OncoNano’s lead product, ONM-100, is an injectable imaging agent that targets the acidic pH within tumors to better distinguish cancer cells from healthy ones during surgery. OncoNano said the new funding was arranged […]
Original Article: OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 MillionNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...